---
title: "Fluid-walled microfluidics isolates migratory cancer cell subpopulations in standard Petri dishes"
id: "biorxiv-13-identification-and-isolation-of-migratory-subpopulations-of-cancer-cells-using"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-13-identification-and-isolation-of-migratory-subpopulations-of-cancer-cells-using"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.11.11.765957v1?rss=1"
published_at: "2026-11-13T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Fluid-walled microfluidics isolates migratory cancer cell subpopulations in standard Petri dishes
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-13-identification-and-isolation-of-migratory-subpopulations-of-cancer-cells-using
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.11.11.765957v1?rss=1)
- **Published At:** 2026-11-13T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The authors developed a rapid method to jet-print dumbbell-shaped microenvironments with **fluid walls** directly in standard Petri dishes, using standard growth media and an immiscible oil. - Spatial confinement of cells and chemoattractant was achieved by introducing prostate cancer cells and bovine serum into opposite ends, exploiting transient local differences in Laplace pressure to position liquids. - The platform permits automated, live-cell imaging on conventional microscopes because the confining fluid walls are optically transparent, enabling real-time observation of directed movement (chemotaxis). - Investigators used a custom machine-learning segmentation model to classify distinct migratory subpopulations by morphology and motility metrics derived from time-lapse imaging. - The reconfigurable nature of the fluid walls allowed the team to isolate and retrieve rapidly migrating single cells for downstream analysis. - Data indicated that the system can resolve heterogeneity in migration at single-cell resolution in an accessible format; the source did not report detailed downstream molecular analyses or clinical translation pathways. - The study is a preprint and has not undergone peer review; authors declared a competing interest: two co-founders hold equity in a company that provided support and equipment. - Funding sources included the Medical Research Council, Rosetrees Trust, and The John Black Charitable Foundation; supplementary material is available with the preprint.
## Clinical Analysis & Structured Key Points
[](https://www.biorxiv.org/cdn-cgi/content?id=Ku46Q.ri9AlhP9BBp0a5gSkGUe.c1Q6dy4GARhOr15I-1794580504.8388677-1.2.1.1-70j3xr3FuVpz9QwCFINt.xNbpW4g3iUxLqunJN9ewOHyY6prXeGezeAEcRGby1Mn) [Skip to main content](https://www.biorxiv.org/content/10.64898/2026.11.11.765957v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.11.11.765957v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # Identification and isolation of migratory subpopulations of cancer cells using microfluidics with fluid walls [ View ORCID Profile](http://orcid.org/0000-0002-5124-6073)Joseph A. E. Morgan, [ View ORCID Profile](http://orcid.org/0000-0002-3321-8554)Daniele T Cotton, [ View ORCID Profile](http://orcid.org/0000-0003-1889-6530)Srinivasa R Rao, [ View ORCID Profile](http://orcid.org/0000-0002-6639-188X)Peter R Cook, James Edwards, [ View ORCID Profile](http://orcid.org/0000-0003-4995-2582)Alfonso A Castrejon-Pita, [ View ORCID Profile](http://orcid.org/0000-0002-1257-5659)Claire Edwards, [ View ORCID Profile](http://orcid.org/0000-0001-5264-1561)Edmond J Walsh doi: https://doi.org/10.64898/2026.11.11.765957 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Joseph A. E. Morgan University of Oxford * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Joseph%2BA.%2BE.%2BMorgan%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Morgan%20JA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AJoseph%2BA.%2BE.%2BMorgan%2B) * [ORCID record for Joseph A. E. Morgan](http://orcid.org/0000-0002-5124-6073 "Open in new tab") Daniele T Cotton University of Oxford * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Daniele%2BT%2BCotton%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Cotton%20DT&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ADaniele%2BT%2BCotton%2B) * [ORCID record for Daniele T Cotton](http://orcid.org/0000-0002-3321-8554 "Open in new tab") Srinivasa R Rao University of Oxford * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Srinivasa%2BR%2BRao%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Rao%20SR&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ASrinivasa%2BR%2BRao%2B) * [ORCID record for Srinivasa R Rao](http://orcid.org/0000-0003-1889-6530 "Open in new tab") Peter R Cook University of Oxford * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Peter%2BR%2BCook%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Cook%20PR&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3APeter%2BR%2BCook%2B) * [ORCID record for Peter R Cook](http://orcid.org/0000-0002-6639-188X "Open in new tab") James Edwards University of Oxford * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=James%2BEdwards%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Edwards%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AJames%2BEdwards%2B) Alfonso A Castrejon-Pita University of Oxford * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Alfonso%2BA%2BCastrejon-Pita%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Castrejon-Pita%20AA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AAlfonso%2BA%2BCastrejon-Pita%2B) * [ORCID record for Alfonso A Castrejon-Pita](http://orcid.org/0000-0003-4995-2582 "Open in new tab") Claire Edwards University of Oxford * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Claire%2BEdwards%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Edwards%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AClaire%2BEdwards%2B) * [ORCID record for Claire Edwards](http://orcid.org/0000-0002-1257-5659 "Open in new tab") Edmond J Walsh University of Oxford * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Edmond%2BJ%2BWalsh%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Walsh%20EJ&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AEdmond%2BJ%2BWalsh%2B) * [ORCID record for Edmond J Walsh](http://orcid.org/0000-0001-5264-1561 "Open in new tab") * For correspondence: edmond.walsh@eng.ox.ac.uk * [Abstract](https://www.biorxiv.org/content/10.64898/2026.11.11.765957v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5958111/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.11.11.765957v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5958111/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.11.11.765957v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5958111/1) * [Supplementary material](https://www.biorxiv.org/content/10.64898/2026.11.11.765957v1.supplementary-material)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_data/node:5958111/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.11.11.765957v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5958111/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Microfluidic assays have great potential for investigating cancer cell migration, a key process underlying metastasis which remains a major clinical challenge. However, adoption by biologists is limited due to complex fabrication and operation methods combined with difficulty in retrieving cells of interest. We jet-print dumbbell-shaped microfluidic environments with fluid walls in standard Petri dishes in seconds using standard growth media and immiscible oil. Prostate cancer cells and chemoattractant (bovine serum) are introduced into each end using local transient differences in Laplace pressure to enable spatial confinement. Automated live-cell imaging monitors chemotaxis towards serum using standard microscopes, as the confining fluid walls are optically transparent. Distinct subpopulations of migratory cells exhibit different morphologies and motilities, assessed using a custom machine-learning segmentation model. Then, we leverage the reconfigurability of fluid walls to isolate and retrieve rapidly-migrating single cells. This demonstrates that fluid-walled microfluidics is a versatile and accessible approach for investigating cancer cell migration at single-cell resolution, offering new opportunities to examine cellular heterogeneity in metastasis. ### Competing Interest Statement P. R. C. and E. J. W. co-founded, and hold equity in, IotaSciences Ltd who provide support to J.A.E.M and equipment for the study. ## Funder Information Declared Medical Research Council, https://ror.org/03x94j517, MR/N013468/1 Rosetrees Trust, https://ror.org/04e3zg361, PGS21/10073 The John Black Charitable Foundation, CF-2024-M-2\114 Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.biorxiv.org/content/10.64898/2026.11.11.765957v1?rss=1#page) [ Previous](https://www.biorxiv.org/content/10.64898/2026.11.11.765819v1 "Expanding Plasma Proteome Coverage While Preserving Biological Signatures: A Systematic Characterization of Enrichment and Preanalytical Variables")[Next ](https://www.biorxiv.org/content/10.64898/2026.11.11.766025v1 "MERTK and RAC1P29S Drive Melanoma Cannibalism of T cells") Posted November 13, 2026. [ Download PDF](https://www.biorxiv.org/content/10.64898/2026.11.11.765957v1.full.pdf) Print/Save Options [Download PDF](https://www.biorxiv.org/content/biorxiv/early/2026/11/13/2026.11.11.765957.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.biorxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [Supplementary Material ](https://www.biorxiv.org/content/10.64898/2026.11.11.765957v1.supplementary-material) [ Email](https://www.biorxiv.org/ "Email this Article") [ Share](https://www.biorxiv.org/) Identification and isolation of migratory subpopulations of cancer cells using microfluidics with fluid walls Joseph A. E. Morgan, Daniele T Cotton, Srinivasa R Rao, Peter R Cook, James Edwards, Alfonso A Castrejon-Pita, Claire Edwards, Edmond J Walsh bioRxiv 2026.11.11.765957; doi: https://doi.org/10.64898/2026.11.11.765957 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Share This Article: Copy [![Twitter logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.biorxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.11.765957v1%26text%3DIdentification%2520and%2520isolation%2520of%2520migratory%2520subpopulations%2520of%2520cancer%2520cells%2520using%2520microfluidics%2520with%2520fluid%2520walls "Share this on Twitter") [![Facebook logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.biorxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.11.765957v1%26t%3DIdentification%2520and%2520isolation%2520of%2520migratory%2520subpopulations%2520of%2520cancer%2520cells%2520using%2520microfluidics%2520with%2520fluid%2520walls "Share on Facebook") [![LinkedIn logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.biorxiv.org/highwire_log/share/linkedin?link=http%
## Related Clinical Research

- [Continuous karyotypic instability and structural flux in acral melanoma genomes](https://medichelpline.com/clinical-feed/biorxiv-0-continuous-karyotypic-and-cryptic-structural-fluctuations-drive-acral-melanoma.md)
- [LATS1 as a context-specific regulator in melanoma: preprint reports a zebrafish lats1 knockout mod](https://medichelpline.com/clinical-feed/biorxiv-0-integrative-analysis-identifies-lats1-as-a-context-specific-regulator-of.md)
- [Dual immune checkpoint inhibition for melanoma brain metastases: safety and efficacy meta-analysis](https://medichelpline.com/clinical-feed/pubmed-42934318.md) (DOI: 10.1007/s10143-026-04538-w)
- [53L10 T‑cell engager tribody for immunotherapy of multiple solid tumors — Frontiers in Immunology](https://medichelpline.com/clinical-feed/frontiers-in-immunology-11-53l10-t-cell-engager-tribody-for-immunotherapy-of-multiple-solid-tumors.md)
- [Genome-wide genetic dataset generated for the Australian 45 and Up Study](https://medichelpline.com/clinical-feed/medrxiv-17-a-genome-wide-genetic-data-resource-for-the-45-and-up-study.md)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.